Related Experiment Video
Updated: May 8, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure
Annika Mutanen1, Päivi Heikkilä2, Jouko Lohi2
1Section of Pediatric Surgery, Children's Hospital, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Insights
Elevated serum FGF21 levels in pediatric intestinal failure (IF) patients indicate liver steatosis. This finding, linked to parenteral nutrition duration and small bowel length, suggests FGF21 may aid in diagnosing liver steatosis in IF.
Area of Science:
- Endocrinology
- Hepatology
- Pediatric Gastroenterology
Background:
- Fibroblast Growth Factor 21 (FGF21) is implicated in glucose and lipid metabolism and liver steatosis.
- Pediatric onset intestinal failure (IF) presents unique metabolic challenges.
- Understanding FGF21's role in IF is crucial for managing associated complications.
Purpose of the Study:
- To evaluate serum FGF21 levels in children with intestinal failure (IF).
- To determine the association between FGF21 levels and liver steatosis in pediatric IF.
- To explore the relationship between FGF21, liver steatosis, and clinical factors in IF.
Main Methods:
- Serum FGF21 was measured in 35 pediatric IF patients and 59 healthy controls.
- Liver biopsies were performed on 30 IF patients to assess steatosis and fibrosis.
- Statistical analyses, including multivariate regression, were used to correlate FGF21 levels with clinical and histological findings.
Main Results:
- Serum FGF21 levels were significantly higher in IF patients compared to controls.
- Patients with liver steatosis exhibited markedly higher FGF21 concentrations and more advanced liver fibrosis.
- FGF21 levels correlated with the grade of steatosis and were associated with parenteral nutrition duration and remaining small bowel length.
Conclusions:
- Increased serum FGF21 in pediatric IF reflects liver steatosis.
- Both FGF21 levels and liver steatosis are associated with parenteral nutrition duration and extent of small intestinal resection.
- Serum FGF21 may serve as a useful non-invasive biomarker for diagnosing liver steatosis in pediatric IF patients.
Background & Aims:
Previously, FGF21 has been related to glucose and lipid metabolism and liver steatosis. Our aim was to evaluate serum FGF21 levels in pediatric onset intestinal failure (IF).
Methods:
Serum FGF21 was measured in 35 IF patients at median age of 7.8 years (range 0.2-27) and 59 matched healthy controls. Thirty patients underwent liver biopsy.
Results:
Serum FGF21 levels were increased in patients compared to controls [229 pg/ml (21-20,345) vs. 133 pg/ml (7-1607), p=0.018]. Frequency of liver steatosis (60% vs. 50%, p=0.709) was similar during (6/10) and after (10/20) weaning off parenteral nutrition (PN). Patients with steatosis had markedly higher serum FGF21 concentration [626 pg/ml (21-20,345) vs. 108 pg/ml (32-568), p=0.002] and more advanced liver fibrosis [Metavir stage 1.6 (0-4) vs. 0.7 (0-3), p=0.020] without associated inflammation or Mallory body formation. Serum FGF21 levels reflected the degree of steatosis [FGF21 in grade 3 vs. grades 0-2, p<0.001; grade 1 vs. controls, p=0.002], and correlated with steatosis grade (r=0.589, p=0.001). Hepatic steatosis and serum FGF21 showed similar associations with duration of PN and remaining small bowel length (p<0.05 for all). In a multivariate regression model, liver steatosis grade (β=0.630, p=0.001) predicted serum FGF21 concentration.
Conclusions:
In pediatric IF increased serum FGF21 levels reflect liver steatosis, while both are exclusively associated with duration of PN and extent of small intestinal resection. Liver steatosis is coupled with progression of fibrosis without accompanying inflammation. Serum FGF21 assay may be useful for diagnosing liver steatosis in IF patients.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Cirrhosis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

